Larry Biegelsen
Stock Analyst at Wells Fargo
(3.71)
# 2,077
Out of 5,040 analysts
1354
Total ratings
50.1%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterated: Buy | $112 | $98.49 | +13.72% | 117 | Oct 5, 2026 | |
| AXGN Axogen | Reiterated: Buy | $48 | $36.18 | +32.67% | 4 | Oct 2, 2026 | |
| IART Integra LifeSciences Holdings | Reiterated: Hold | $18 → $15 | $13.41 | +11.86% | 15 | Oct 2, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $282 | $256.48 | +9.95% | 100 | Oct 2, 2026 | |
| DXCM DexCom | Reiterated: Buy | $90 | $84.41 | +6.62% | 65 | Sep 29, 2026 | |
| BSX Boston Scientific | Rated: Hold | $50 → $48 | $42.04 | +14.18% | 52 | Sep 24, 2026 | |
| BBNX Beta Bionics | Initiated Coverage: Buy | $28 | $17.43 | +60.64% | 1 | Sep 23, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $18 | $17.15 | +4.96% | 60 | Sep 18, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Buy | CHF 80.72 → CHF 71.57 | CHF 52.20 | +37.10% | 34 | Sep 18, 2026 | |
| SYK Stryker | Rated: Buy | $348 | $276.97 | +25.65% | 41 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $66 → $61 | $54.30 | +12.34% | 45 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 | $87.75 | +18.52% | 91 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $17.43 | +89.33% | 6 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $19.80 | +31.31% | 5 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 | $64.22 | +32.36% | 29 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 → $39 | $47.63 | -18.12% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.63 | +141.33% | 5 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 | $12.38 | +53.47% | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $99 | $73.33 | +35.01% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $4.86 | +85.38% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $103 | $88.88 | +15.89% | 43 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $14 | $10.35 | +35.27% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $255 → $144 | $134.47 | +7.09% | 40 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $66.69 | -16.03% | 39 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 | $317.52 | +17.79% | 48 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $74 → $83 | $85.25 | -2.64% | 43 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $46 | $45.11 | +1.97% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $138 → $178 | $161.29 | +10.36% | 56 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $487 | $415.41 | +17.23% | 61 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $25.77 | +8.65% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $21 → $27 | $15.68 | +72.25% | 31 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $86.41 | -18.99% | 3 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $116 → $138 | $124.19 | +11.12% | 20 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 → $17 | $14.22 | +19.55% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $84 | $126.65 | -33.68% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $100 | $84.24 | +18.71% | 65 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $184 → $157 | $182.75 | -14.09% | 40 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $280 → $270 | $226.73 | +19.08% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $19 | $23.90 | -20.50% | 36 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.81 | +65.75% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9401 | - | 15 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $100.12 | n/a | 3 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $1.4 | $9.00 | n/a | 3 | Sep 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $143.11 | n/a | 1 | Jan 4, 2010 |
Abbott Laboratories
Oct 5, 2026
Reiterated: Buy
Price Target: $112
Current: $98.49
Upside: +13.72%
Axogen
Oct 2, 2026
Reiterated: Buy
Price Target: $48
Current: $36.18
Upside: +32.67%
Integra LifeSciences Holdings
Oct 2, 2026
Reiterated: Hold
Price Target: $18 → $15
Current: $13.41
Upside: +11.86%
Johnson & Johnson
Oct 2, 2026
Rated: Buy
Price Target: $282
Current: $256.48
Upside: +9.95%
DexCom
Sep 29, 2026
Reiterated: Buy
Price Target: $90
Current: $84.41
Upside: +6.62%
Boston Scientific
Sep 24, 2026
Rated: Hold
Price Target: $50 → $48
Current: $42.04
Upside: +14.18%
Beta Bionics
Sep 23, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $17.43
Upside: +60.64%
Bausch + Lomb
Sep 18, 2026
Reiterated: Hold
Price Target: $18
Current: $17.15
Upside: +4.96%
Alcon Inc.
Sep 18, 2026
Reiterated: Buy
Price Target: CHF 80.72 → CHF 71.57
Current: CHF 52.20
Upside: +37.10%
Stryker
Sep 16, 2026
Rated: Buy
Price Target: $348
Current: $276.97
Upside: +25.65%
Sep 9, 2026
Reiterated: Hold
Price Target: $66 → $61
Current: $54.30
Upside: +12.34%
Sep 9, 2026
Reiterated: Buy
Price Target: $104
Current: $87.75
Upside: +18.52%
Sep 8, 2026
Reiterated: Buy
Price Target: $33
Current: $17.43
Upside: +89.33%
Sep 8, 2026
Reiterated: Buy
Price Target: $26
Current: $19.80
Upside: +31.31%
Aug 25, 2026
Rated: Buy
Price Target: $85
Current: $64.22
Upside: +32.36%
Aug 14, 2026
Rated: Buy
Price Target: $37 → $39
Current: $47.63
Upside: -18.12%
Aug 13, 2026
Reiterated: Buy
Price Target: $16
Current: $6.63
Upside: +141.33%
Aug 12, 2026
Rated: Buy
Price Target: $19
Current: $12.38
Upside: +53.47%
Aug 7, 2026
Reiterated: Buy
Price Target: $103 → $99
Current: $73.33
Upside: +35.01%
Aug 6, 2026
Reiterated: Hold
Price Target: $9
Current: $4.86
Upside: +85.38%
Aug 6, 2026
Rated: Hold
Price Target: $90 → $103
Current: $88.88
Upside: +15.89%
Aug 5, 2026
Reiterated: Buy
Price Target: $28 → $14
Current: $10.35
Upside: +35.27%
Aug 5, 2026
Downgraded: Hold
Price Target: $255 → $144
Current: $134.47
Upside: +7.09%
Aug 4, 2026
Reiterated: Hold
Price Target: $56
Current: $66.69
Upside: -16.03%
Aug 3, 2026
Reiterated: Hold
Price Target: $374
Current: $317.52
Upside: +17.79%
Jul 31, 2026
Rated: Hold
Price Target: $74 → $83
Current: $85.25
Upside: -2.64%
Jul 30, 2026
Reiterated: Hold
Price Target: $39 → $46
Current: $45.11
Upside: +1.97%
Jul 30, 2026
Rated: Buy
Price Target: $138 → $178
Current: $161.29
Upside: +10.36%
Jul 23, 2026
Reiterated: Buy
Price Target: $487
Current: $415.41
Upside: +17.23%
Jul 15, 2026
Rated: Buy
Price Target: $28
Current: $25.77
Upside: +8.65%
Jun 1, 2026
Upgraded: Buy
Price Target: $21 → $27
Current: $15.68
Upside: +72.25%
May 22, 2026
Reiterated: Hold
Price Target: $70
Current: $86.41
Upside: -18.99%
May 8, 2026
Reiterated: Hold
Price Target: $116 → $138
Current: $124.19
Upside: +11.12%
May 4, 2026
Rated: Hold
Price Target: $14 → $17
Current: $14.22
Upside: +19.55%
Feb 20, 2026
Reiterated: Hold
Price Target: $80 → $84
Current: $126.65
Upside: -33.68%
Feb 11, 2026
Reiterated: Buy
Price Target: $96 → $100
Current: $84.24
Upside: +18.71%
Feb 10, 2026
Reiterated: Hold
Price Target: $184 → $157
Current: $182.75
Upside: -14.09%
Jan 30, 2026
Reiterated: Hold
Price Target: $280 → $270
Current: $226.73
Upside: +19.08%
Dec 12, 2025
Reiterated: Hold
Price Target: $24 → $19
Current: $23.90
Upside: -20.50%
Nov 13, 2025
Reiterated: Hold
Price Target: $3
Current: $1.81
Upside: +65.75%
Oct 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.9401
Upside: -
Aug 2, 2018
Reiterated: Buy
Price Target: $26 → $20
Current: $100.12
Upside: n/a
Sep 26, 2013
Downgraded: Hold
Price Target: $15 → $1.4
Current: $9.00
Upside: n/a
Jan 4, 2010
Upgraded: Buy
Price Target: n/a
Current: $143.11
Upside: n/a